Immunomodulation in allergic rhinitis: Insights from Th2 cells and NLRP3/IL‐18 pathway
Cell Biochemistry and Function · 2024
DOI: 10.1002/cbf.3997 ↗At a glance
Journal article in Cell Biochemistry and Function, 2024. Written by Xiaoyan Hu and 5 co-authors. Institution: Department of Pathogen Biology, School of Basic Medicine Southwest Medical University, Luzhou, China. Major MEDLINE topics: Th2 Cells, Rhinitis, Allergic. Cited 20 times so far (Crossref); 21 references. Funded by: Sichuan Science and Technology Program, HeJiang and Southwest Medical University.
Abstract (original language)
Allergic rhinitis (AR) is characterized by nasal symptoms such as rubbing and sneezing, often triggered by allergen exposure. The purpose of this study is to dissect the roles of NLRP3‐mediated immune modulation and macrophage pyroptosis in modulating T cell differentiation within the context of ovalbumin (OVA)‐induced AR in mice. OVA‐induced AR was established in mice, evaluating nasal symptoms, macrophage infiltration, cytokine levels, and T cell differentiation. Manipulations using NLRP3−/−, ASC−/− mice, clodronate liposome treatment, and NLRP3 inhibitor MCC950 were performed to assess their impact on AR symptoms and immune responses. Following OVA stimulation, increased nasal symptoms were observed in the OVA group along with augmented GATA3 expression and elevated IL‐4 and IL‐1b levels, indicative of Th2 polarization and cellular pyroptosis involvement. NLRP3−/− and ASC−/− mice exhibited reduced CD3+ T cells post OVA induction, implicating cellular pyroptosis in AR. Macrophage depletion led to decreased IgE levels, highlighting their involvement in allergic responses. Further investigations revealed enhanced macrophage pyroptosis, influencing Th1/Th2 differentiation in AR models. IL‐18 released through NLRP3‐mediated pyroptosis induced Th2 differentiation, distinct from IL‐1b. Additionally, MCC950 effectively mitigated AR symptoms by modulating Th2 responses and reducing macrophage infiltration. This comprehensive study unravels the pivotal role of NLRP3‐mediated immune modulation and macrophage pyroptosis in Th1/Th2 balance regulation in OVA‐induced AR. Targeting NLRP3 pathways with MCC950 emerged as a promising strategy to alleviate AR symptoms, providing insights for potential therapeutic interventions in AR management.
Subjects
MeSH terms (MEDLINE)
Author keywords
Substances
Authors and institutions
- Department of Pathogen Biology, School of Basic Medicine Southwest Medical University, Luzhou, China.
- Public Center of Experimental Technology of Pathogen Biology Technology Platform Southwest Medical University, Luzhou, China.
- Department of Otolaryngology Head and Neck Surgery, Affiliated Hospital of Southwest Medical University, Luzhou, China.
Funding
- Sichuan Science and Technology Program
- HeJiang and Southwest Medical University
Cite
APA
Hu, X., Liu, S., Jing, Z., He, Y., Qin, G., & Jiang, L. (2024). Immunomodulation in allergic rhinitis: Insights from Th2 cells and NLRP3/IL‐18 pathway. Cell Biochemistry and Function. https://doi.org/10.1002/cbf.3997
Vancouver
Hu X, Liu S, Jing Z, He Y, Qin G, Jiang L. Immunomodulation in allergic rhinitis: Insights from Th2 cells and NLRP3/IL‐18 pathway. Cell Biochemistry and Function. 2024. doi:10.1002/cbf.3997
BibTeX
@article{Hu2024,
author = {Hu, Xiaoyan and Liu, Shuang and Jing, Zhang and He, Yuxiao and Qin, Gang and Jiang, Liang},
title = {Immunomodulation in allergic rhinitis: Insights from Th2 cells and NLRP3/IL‐18 pathway},
journal = {Cell Biochemistry and Function},
year = {2024},
doi = {10.1002/cbf.3997}
}
EUVIMED